Solana Co. Form 8-K Summary
Business Context and Reporting Period
Solana Co. (formerly Helius Medical Technologies, Inc.), a Delaware corporation, filed this Current Report on Form 8-K on March 30, 2026. The filing announces financial results for the fiscal quarter and fiscal year ended December 31, 2025. The company's Class A Common Stock trades on The Nasdaq Stock Market under the symbol HSDT.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. The filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text, as the specific financial results are contained within the referenced press release.
Guidance, Outlook, and Risks
The filing incorporates a press release by reference but does not contain specific management commentary, forward-looking guidance, risk factors, or details on contingencies within the body of this 8-K document. The text explicitly states that the information in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 30, 2026) for actual revenue, earnings, and cash flow figures.
- Verify the company's name change from Helius Medical Technologies, Inc. to Solana Co. and its impact on historical data comparability.
- Confirm the trading symbol HSDT on The Nasdaq Stock Market.
- Check for any subsequent filings that may provide the detailed financial statements referenced but not included in this 8-K.